Quick Answer
Clearside Biomedical, Inc. reported Earnings Per Share Diluted of $0.47 (loss) per share for the year ending 2024.
- Clearside Biomedical, Inc. showed an increase of +11.3% in Earnings Per Share Diluted from 2023 to 2024.
- This data is from Clearside Biomedical, Inc.'s annual report (Form 10-K), filed with the SEC on March 27, 2025.
- XBRL data for this metric is available from 2020 to 2024 (5 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Quarterly values from 10-Q filings: Q3 2021: $0.08 (loss) per share | Q1 2022: $0.13 (loss) per share | Q2 2022: $0.13 (loss) per share | Q3 2022: $0.13 (loss) per share | Q1 2023: $0.15 (loss) per share | Q2 2023: $0.15 (loss) per share | Q3 2023: $0.15 (loss) per share | Q1 2024: $0.17 (loss) per share | Q2 2024: $0.10 (loss) per share | Q3 2024: $1.54 (loss) per share | Q1 2025: $0.11 (loss) per share | Q2 2025: $0.06 (loss) per share | Q3 2025: $1.14 (loss) per share.
- Over the full 5 years of available data (2020 to 2024), Clearside Biomedical, Inc.'s Earnings Per Share Diluted has declined by 20.5%.
- Historical annual values: Fiscal year 2024: $0.47 (loss) per share | Fiscal year 2023: $0.53 (loss) per share | Fiscal year 2022: $0.55 (loss) per share | Fiscal year 2021: $0.01 per share | Fiscal year 2020: $0.39 (loss) per share.
- Data sourced from SEC EDGAR public filings as of August 8, 2026.
Last verified: